Lorenzo, R. B., Lorenzo, L. S., & González-Martín, A. (2017). Will the carboplatin-paclitaxel-bevacizumab combination become the preferred option as the first line in advanced cervical cancer? A small experience from a single oncologic Center:  . Cancer Breaking News, 5(1), 21–24. https://doi.org/10.19156/cbn.2017.0035